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ABSTRACT

INTRODUCTION

The rapid growth of bio-therapeutic
manufacturing
has
created
significant demand for workflow
solutions featuring greater product
yield, lower production costs, and
accelerated development timelines.
To address these demands,
developers have moved away from
“one-size-fits-all” approaches and
are
increasingly
focused
on
solutions that address the specific
needs of diverse bioproduction
processes. Given this shift toward
aa
process-specific solutions, Thermo Scientific has introduced a
series of application-specific enhancements to the HyPerformaTM
Single Use Bioreactor (S.U.B.) product platform (Figure 1), each
tailored to the unique requirements of perfusion, intensified fedbatch, and adherent cell cultures (Table 1).

In 2006, Thermo Scientific released the HyPerformaTM S.U.B. – the
first single-use stirred tank bioreactor on the market. Since 2006,
Thermo Scientific has continued to innovate by releasing a number
of improvements to the first generation S.U.B. including the first 2000
L S.U.B. (2010), a low-shear drilled hole sparger (2014), and the 5:1
HyPerformaTM S.U.B. allowing operation at a 5:1 turndown ratio
(2016/2017). In this tradition, we introduce the enhanced
HyperformaTM S.U.B. for perfusion, fed-batch, and microcarriers
Figure 1. Cross section of each generation of HyPerformaTM S.U.B

• Greater mixing power
• Greater mass transfer
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• Greater mixing power
• Greater mass transfer
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where µ represents the fluid kinematic viscosity, and the remaining
parameters have been described previously. The value of λ should
be limited to approximately half the microcarrier diameter to avoid
generating destructive eddies. Each enhanced S.U.B. features an
upsized impeller that delivers greater mixing power and less
destructive eddies than legacy S.U.B. designs (Figure 2a-b).
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Mixing power input per volume (PIV) is an important cell-culture
parameter and can be described as:
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• Lower tip speed
• High turndown ratio
• Decantation lines
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Table 1. Application-specific requirements for perfusion, fed-batch, and microcarriers
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Figure 2. PIV plotted with respect to mixing speed and (a) Kolmogorov length plotted
with respect to PIV (b) for the Enhanced (solid) and Legacy (dashed) S.U.B.s.

2:1 Legacy
S.U.B.

Perfusion

the impeller tip speed can produce shear forces that damage cells
and microcarriers. Shear forces on microcarriers can be described
by the Kolmogorov length (λ), which characterizes the minimum eddy
size of a given system:

80
60
40
20

200
160
120
80
40

0

Where Np represents the impeller power number, ρ represents the
fluid density, Ni represents the impeller speed, Di represents the
impeller diameter, and V represents the vessel volume. At high PIV,

Minimum λ for microcarriers
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RESULTS
Figure 4. VCD (solid markers) and cell viability (hollow markers) plotted over two
week fed-batch cell culture with the enhanced S.U.B.
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Enhanced S.U.B. for Perfusion

Adherent cell culture is an increasingly attractive strategy for
producing vaccines and viral vectors for gene and cell therapies.3
However, reliable scale up of adherent cell cultures with
microcarriers is difficult due to the sensitivity of both the cells and
microcarriers to shear (Figure 5a-b). To address this sensitivity
limitation, we engineered an enhanced Thermo Scientific
HyPerformaTM S.U.B. featuring the same upsized impeller and
turndown ratio as the enhanced fed-batch, as well as optimized port
configuration for media decantation, allowing high cell densities to be
achieved on microcarriers (Figure 6).

30

Time (day)
VCD

12

Enhanced S.U.B. for Microcarriers

0.12

DHS Flow (VVM)

9

50 L enhanced
250 L enhanced
500 L enhanced

MATERIALS AND METHODS

Viability

Enhanced S.U.B. for Fed-Batch
Increasing demand for high-product yields and greater risk mitigation
in bioproduction processes has pushed legacy S.U.B. performance
to its technological limits. To address the growing intensification of
fed-batch bioproduction processes, the enhanced Thermo Scientific
HyPerformaTM S.U.B. features an upsized impeller and improved
DHS design, which sustains high cell viability in culture (Figure 4). In
addition, the enhanced S.U.B. can operate at a 4:1 turndown ratio.2
The ability of the enhanced S.U.B. to operate at low liquid volumes
reduces the number of vessels required to reach production scale
culture (e.g. 2000 L). Fewer vessels in a process seed train reduces
risks associated with transferring high-density cell cultures between
vessels while simplifying bioprocess development.

Figure 5. (a) Impeller tip speed in the enhanced (solid) and legacy (dashed) S.U.B.s
(b) Low tip speed of enhanced S.U.B. impeller reduces damage to cells and
microcarriers.
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Figure 3. (a) Apparent kLa plotted with respect to O2 flow rate in vessel volumes per
minute (VVM) for enhanced (solid) and legacy (dashed) S.U.B.s. (b) Performance of
enhanced S.U.B. throughout 25-day perfusion cell culture.
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Figure 6. Adherent cell culture density on microcarriers using enhanced S.U.B.
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Perfusion cell culture conditions are especially demanding and
require high mixing PIV, high mass transfer, and ATF/TFF
connectivity. To address the unique demands of perfusion cell
culture, the enhanced Thermo Scientific HyPerformaTM S.U.B.
features an upsized impeller, improved DHS design, and userfriendly port configuration for ATF.1 These enhancements resulted in
up to a 4.3-fold increase in kLa (Figure 3a). When used in perfusion
cell culture, the enhanced S.U.B. was able to support a viable cell
density (VCD) of greater than 50 M/mL for more than 2 weeks,
reaching a maximum VCD of nearly 264 M/mL on day 25 (Figure
3b).
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Enhanced S.U.B. for Perfusion

4:1 Cell Culture of Vero Cells on Microcarriers
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CHO-DP12 cells (ATCC CRL-12445TM) were cultured in GibcoTM CD
OptiCHO medium in an enhanced 50 L, 250 L, and 500 L
HyPerformaTM S.U.B. for this study. Mixing power input per volume
(PIV) throughout the culture varied from 20 – 100 W/m3. Mass
transfer was achieved by sparging O2 through an enhanced DHS at
rates up to 0.2 VVM. An antifoam sensor was used to monitor foam
level. Alternating tangential flow (ATF) filtration was performed using
a single-use XCellTM ATF 6. Culture conditions were controlled
throughout using a HyPerformaTM G3Pro controller.

Enhanced S.U.B. for Fed-Batch
CHO-S cells were cultured in GibcoTM Dynamis medium and
supplemented with GibcoTM EfficientFeed C+ for this study. To
demonstrate scalability, cells were cultured in 50 L, 250 L, and 500 L
HyPerformaTM S.U.B.s. Mixing PIV was maintained at 20 W/m3
throughout the cultures. Mass transfer was achieved by sparging O2
through an enhanced DHS at rates up to 0.05 VVM. Culture
conditions were controlled throughout using a HyPerformaTM G3Pro
controller.

Enhanced S.U.B. for Microcarriers
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Vero cells (ATCC, CCL-81TM) were cultured in GibcoTM VP-SFM with
Cytodex® 1 microcarriers at a concentration of 3 g/L throughout the
study. To demonstrate scalability, cells were cultured in 50 L, 250 L,
and 500 L with average agitation rates of 42.8 RPM, 24.9 RPM, and
19.5 RPM, respectively. Cell culture media was exchanged at a rate
of 0.5 VVD via decantation.

CONCLUSIONS
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To address the trend toward specialization in bioproduction, Thermo
ScientificTM has upgraded the HyPerformaTM S.U.B. product platform
to feature application-specific enhancements for:
• Perfusion
• Fed-batch
• Adherent cell culture with microcarriers
Thermo Fisher Scientific is committed to developing best-in-class
solutions and is proud to introduce the enhanced HyPerformaTM
S.U.B. line in this tradition.
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